PENTAMETHYLMELAMINE (PMM): PHASE I CLINICAL AND PHARMACOKINETIC STUDIES = PENTAMETHYLMELAMINE: ETUDE CLINIQUE PHASE I ET PHARMACOCINETIQUEMUINDI JRF; NEWELL DR; SMITH IE et al.1983; BRITISH JOURNAL OF CANCER; ISSN 0007-0920; GBR; DA. 1983; VOL. 47; NO 1; PP. 27-33; ABS. ENG; BIBL. 26 REF.; GRAPHArticle

A PHASE I AND CLINICAL PHARMACOLOGY STUDY OF INTRAVENOUSLY ADMINISTERED CARMINOMYCIN IN CANCER PATIENTS IN THE UNITED STATESCOMIS RL; ISSELL BF; PITTMAN K et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 7; PP. 2944-2948; BIBL. 15 REF.Article

PHASE I TRIAL OF INDICINE-N-OXIDE ON TWO DOSE SCHEDULES = ESSAI PHASE I DE L'INDICINE-N-OXYDE SELON DEUX PROTOCOLES DIFFERENTSTAYLOR S; BELT RJ; HAAS CD et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 11; PP. 1988-1991; ABS. ENG; BIBL. 4 REF.; GRAPHArticle

FINAL REPORT ON THE UNITED STATES PHASE 1 CLINICAL TRIAL OF THE HYPOXIC CELL RADIOSENSITIZER, MISONIDAZOLE (R0-07-0582; NSC#261037)PHILLIPS TL; WASSERMAN TH; JOHNSON RJ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 8; PP. 1697-1704; BIBL. 15 REF.Article

ADRIAMYCIN (NSC-123127) PLUS 5-FLUOROURACIL (NSC-19893)= A PHASE I STUDYTRANUM BL; STEPHENS RL; LEHANE DE et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 6; PP. 1163-1165; BIBL. 9 REF.Article

PHASE I STUDY OF L-ALANOSINE (NSC 15353) = ETUDE PHASE I DE LA L-ALANOSINE (NSC 15353)GOLDSMITH MA; OHNUMA T; SPIGELMAN M et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 3; PP. 378-380; ABS. ENG; BIBL. 8 REF.; GRAPHArticle

EARLY TUMOR AND LEUKEMIA RESPONSE TO ALKYL-LYSOPHOSPHOLIPIDS IN A PHASE I STUDYBERDEL WE; SCHLEHE H; FINK U et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 10; PP. 2011-2015; BIBL. 16 REF.Article

PHARMACOKINETICS OF VINCRISTINE INFUSIONJACKSON DV JR; SAGAR SETHI V; SPURR CL et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1043-1048; BIBL. 15 REF.Article

PHASE I CLINICAL TRIAL WITH AMETANTRONE (NSC-287513)PICCART M; ROZENCWEIG M; ABELE R et al.1981; EUR. J. CANCER CLIN. ONCOL.; GBR; DA. 1981; VOL. 17; NO 7; PP. 775-779; BIBL. 9 REF.Article

PHASE I STUDY OF A FIVE-DAY INTERMITTENT SCHEDULE FOR 1,2: 5,6-DIANHYDROGALACTITOL (NSC-132313).EAGAN RT; MOERTEL CG; HAHN RG et al.1976; J. NATION. CANCER INST.; U.S.A.; DA. 1976; VOL. 56; NO 1; PP. 179-181; BIBL. 5 REF.Article

CIS-DIAMINO-DICHLORO-PLATIN (II) IN DER BEHANDLUNG THERAPIERESISTENTER MALIGNER HODENTERATOME. = CIS-DIAMINO-DICHLOROPLATINE DANS LE TRAITEMENT DES TERATOMES MALINS TESTICULAIRES RESISTANTS AU TRAITEMENTOSIEKA R; BRUNTSCH U; GALLMEIER WM et al.1976; DTSCHE MED. WSCHR.; DTSCH.; DA. 1976; VOL. 101; NO 6; PP. 191-199 (6P.); H.T. 1; ABS. ANGL.; BIBL. 24 REF.Article

CLINICAL PHASE I TRIAL OF INOSINE DIALDEHYDE (NSC-118994).KAUFMAN J; MITTELMAN A.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1007-1014; BIBL. 8 REF.Article

RESULTATS DU TRAITEMENT DU LYMPHOGRANULOME ET DE LA LEUCEMIE PAR UN DERIVE D'EPIPODOPHYLLOTOXINE ("VM26" SANDOZ)MILIC N; BORAS T; HANDL S et al.1975; AN. KLIN. BOLNICE "DR M. STOJANOVIC"; JUGOSL.; DA. 1975; VOL. 14; NO 1; PP. 35-45; ABS. ANGL.; BIBL. 12 REF.Article

PHASE I EVALUATION OF PEPLOMYCIN WITH SPECIAL REFERENCE TO PULMONARY TOXICITY = ETUDE PHASE I DE LA PEPLOMYCINE EN PARTICULIER DE LA TOXICITE PULMONAIRESORENSEN PG; RORTH M; HANSEN HH et al.1983; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1983; VOL. 19; NO 3; PP. 319-325; ABS. ENG; BIBL. 16 REF.; GRAPHArticle

PHASE 1 TRIAL OF SPIROGERMANIUM GIVEN BY INFUSION IN A MULTIPLE-DOSE SCHEDULEBUDMAN DR; SCHULMAN P; VINCIGUERRA V et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 173-175; BIBL. 6 REF.Article

A MULTIPLE-DOSE PHASE I TRIAL OF RECOMBINANT LEUKOCYTE A INTERFERON IN CANCER PATIENTSSHERWIN SA; KNOST JA; FEIN S et al.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 248; NO 19; PP. 2461-2466; BIBL. 20 REF.Article

MULTIPLE-DOSE PHASE I TRIALS - NORMAL VOLUNTEERS OR PATIENTS. ONE VIEWPOINTWEISSMAN L.1981; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1981; VOL. 21; NO 10; PP. 385-387; BIBL. 4 REF.Article

CLINICAL TRIAL OF THE ORAL FORM OF A NEW PODOPHYLLATOXIN DERIVATIVE, VP-16-213 (NSC-141540), IN PATIENTS WITH ADVANCED NEOPLASTIC DISEASE.NISSEN NI; HANSEN HH; PEDERSEN H et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1027-1029; BIBL. 5 REF.Article

INITIAL CLINICAL EVALUATION OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD-32), AN ADRIAMYCIN ANALOGBLUM RH; GARNICK MB; ISRAEL M et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 919-923; BIBL. 20 REF.Article

PHASE I CLINICAL TRIAL OF A 3-DAY DIVIDED DOSE SCHEDULE OF IFOSFAMIDE (NSC 109724)NELSON RL; CREAVEN PJ; COHEN MH et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 3; PP. 195-198; BIBL. 9 REF.Article

A PHASE I STUDY OF 5-AZACYTIDINE (NSC-102816)SCHNIDER BI; MAHMOODULLAH BAIG; COLSKY J et al.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 4; PP. 205-212; BIBL. 10 REF.Article

COMPARISON OF THE HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, TWO ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES.ALLEN LM; CREAVEN PJ.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 10; PP. 697-707; BIBL. 2 P. 1/2Article

PHASE I STUDY OF THALICARPINE (NSC-68075), A PLANT ALKALOID OF NOVEL STRUCTURE.CREAVEN PJ; COHEN MH; SELAWRY OS et al.1975; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 1001-1006; BIBL. 9 REF.Article

METHYL-GAG IN PATIENTS WITH MALIGNANT NEOPLASMS: A PHASE 1 REEVALUATIONHART RD; OHNUMA T; HOLLAND JF et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 65-71; BIBL. 21 REF.Article

PHASE 1 STUDY OF L-ALANOSINE USING A DAILY X3 SCHEDULEDOSIK GM; STEWART D; VALDIVIESO M et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 73-76; BIBL. 13 REF.Article